SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-24-006308
Filing Date
2024-02-14
Accepted
2024-02-14 07:30:31
Documents
54
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 788951
2 ex31-1.htm EX-31.1 18017
3 ex31-2.htm EX-31.2 17821
4 ex32-1.htm EX-32.1 9804
5 ex32-2.htm EX-32.2 9883
  Complete submission text file 0001493152-24-006308.txt   3778234

Data Files

Seq Description Document Type Size
6 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT sonn-20231231.xsd EX-101.SCH 34603
7 INLINE XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT sonn-20231231_cal.xml EX-101.CAL 35190
8 INLINE XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT sonn-20231231_def.xml EX-101.DEF 126263
9 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT sonn-20231231_lab.xml EX-101.LAB 237818
10 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT sonn-20231231_pre.xml EX-101.PRE 193815
55 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 517139
Mailing Address 100 OVERLOOK CENTER SUITE 102 PRINCETON NJ 08540
Business Address 100 OVERLOOK CENTER SUITE 102 PRINCETON NJ 08540 609-375-2227
Sonnet BioTherapeutics Holdings, Inc. (Filer) CIK: 0001106838 (see all company filings)

IRS No.: 522102141 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 001-35570 | Film No.: 24632298
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)